Sign in

CIK 0001778922

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SpyGlass Pharma, Inc.

Sign in to watch
Ticker
SGP
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
833044245
Phone
+1 949-284-6904
Business address
15326 ALTON PARKWAY, IRVINE, CA, 92618
Former names
SpyGlassPharma, Inc., SpyGlass Ophthalmics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-09 Khan Bilal Arshad Director Purchase +20,000 $16.00 $320K 25,450
2026-02-09 Khan Bilal Arshad Director Purchase +115,000 $16.00 $1.8M 251,427
2026-02-09 Pardo Geoffrey B Director Conversion +1,875,013 1,875,013
2026-02-09 Pardo Geoffrey B Director Purchase +312,500 $16.00 $5.0M 2,187,513
2026-02-09 Pardo Geoffrey B Director Conversion · Series D Preferred Stock −1,875,013 0
2026-02-09 RA CAPITAL MANAGEMENT, L.P. Director Conversion +2,524,473 2,524,473
2026-02-09 RA CAPITAL MANAGEMENT, L.P. Director Conversion +1,806,644 1,806,644
2026-02-09 RA CAPITAL MANAGEMENT, L.P. Director Purchase +3,441,966 $16.00 $55.1M 5,966,439
2026-02-09 RA CAPITAL MANAGEMENT, L.P. Director Purchase +248,034 $16.00 $4.0M 2,054,678
2026-02-09 RA CAPITAL MANAGEMENT, L.P. Director Conversion · Series C-1 Preferred Stock −1,150,941 0
2026-02-09 RA CAPITAL MANAGEMENT, L.P. Director Conversion · Series C-1 Preferred Stock −767,294 0
2026-02-09 RA CAPITAL MANAGEMENT, L.P. Director Conversion · Series C-2 Preferred Stock −1,150,941 0
2026-02-09 RA CAPITAL MANAGEMENT, L.P. Director Conversion · Series C-2 Preferred Stock −767,294 0
2026-02-09 RA CAPITAL MANAGEMENT, L.P. Director Conversion · Series D Preferred Stock −222,591 0
2026-02-09 RA CAPITAL MANAGEMENT, L.P. Director Conversion · Series D Preferred Stock −272,056 0
2026-02-09 Nielsen Kirk G. Director Conversion · Series B Preferred Stock −1,690,230 0
2026-02-09 Nielsen Kirk G. Director Conversion · Series C-1 Preferred Stock −548,067 0
2026-02-09 Nielsen Kirk G. Director Conversion · Series C-2 Preferred Stock −548,067 0
2026-02-09 Nielsen Kirk G. Director Conversion · Series D Preferred Stock −359,255 0
2026-02-09 Behbahani Ali Director Conversion +1,619,240 1,619,240

Page 1 of 9 · 169 trades